UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 230

Sortiert nach

A Zika Vaccine Targeting NS1 Protein Protects Immunocompetent Adult Mice in a Lethal Challenge Model

Scientific reports, 2017-11, Vol.7 (1), p.14769-11, Article 14769

2017

Link zum Volltext

Verfügbarkeit prüfen

Multiple-Cytokine-Producing Antiviral CD4 T Cells Are Functionally Superior to Single-Cytokine-Producing Cells

Journal of Virology, 2007-08, Vol.81 (16), p.8468-8476

2007

Link zum Volltext

Verfügbarkeit prüfen

Ebola virus - prospects for a novel virus-like-particle-expressing modified vaccinia Ankara-based vaccine

Expert review of vaccines, 2018-09, Vol.17 (9), p.769-771

2018

Link zum Volltext

Verfügbarkeit prüfen

A Single Dose of Modified Vaccinia Ankara expressing Ebola Virus Like Particles Protects Nonhuman Primates from Lethal Ebola Virus Challenge

Scientific reports, 2018-01, Vol.8 (1), p.864-9, Article 864

2018

Link zum Volltext

Verfügbarkeit prüfen

HIV/AIDS Vaccines: 2018

Clinical pharmacology and therapeutics, 2018-12, Vol.104 (6), p.1062-1073

Robinson, Harriet L.

2018

Link zum Volltext

Verfügbarkeit prüfen

Breakthrough of SIV strain smE660 challenge in SIV strain mac239-vaccinated rhesus macaques despite potent autologous neutralizing antibody responses

Proceedings of the National Academy of Sciences - PNAS, 2015-08, Vol.112 (34), p.10780-10785

2015

Link zum Volltext

Verfügbarkeit prüfen

HIV transmitted/founder vaccines elicit autologous tier 2 neutralizing antibodies for the CD4 binding site

PloS one, 2017-10, Vol.12 (10), p.e0177863-e0177863

2017

Link zum Volltext

Verfügbarkeit prüfen

DNA and virus particle vaccination protects against acquisition and confers control of viremia upon heterologous simian immunodeficiency virus challenge

Proceedings of the National Academy of Sciences - PNAS, 2013-02, Vol.110 (8), p.2975-2980

2013

Link zum Volltext

Verfügbarkeit prüfen

Human Immunodeficiency Virus Type 1 Controllers but Not Noncontrollers Maintain CD4 T Cells Coexpressing Three Cytokines

Journal of Virology, 2007-11, Vol.81 (21), p.12071-12076

2007

Link zum Volltext

Verfügbarkeit prüfen

Preclinical Studies of Human Immunodeficiency Virus/AIDS Vaccines: Inverse Correlation between Avidity of Anti-Env Antibodies and Peak Postchallenge Viremia

Journal of Virology, 2009-05, Vol.83 (9), p.4102-4111

2009

Link zum Volltext

Verfügbarkeit prüfen

Non-neutralizing antibodies in prevention of HIV infection

Expert opinion on biological therapy, 2013-02, Vol.13 (2), p.197-207

Robinson, Harriet L.

2013

Link zum Volltext

Verfügbarkeit prüfen

Meta-analysis of HIV-1 vaccine elicited mucosal antibodies in humans

npj vaccines, 2021-04, Vol.6 (1), p.56-56, Article 56

2021

Link zum Volltext

Verfügbarkeit prüfen

One Group's Historical Reflections on DNA Vaccine Development

Human gene therapy, 2018-09, Vol.29 (9), p.966

2018

Link zum Volltext

Verfügbarkeit prüfen

Critical Role for Env as well as Gag-Pol in Control of a Simian-Human Immunodeficiency Virus 89.6P Challenge by a DNA Prime/Recombinant Modified Vaccinia Virus Ankara Vaccine

Journal of Virology, 2002-06, Vol.76 (12), p.6138-6146

2002

Link zum Volltext

Verfügbarkeit prüfen

Different Patterns of Immune Responses but Similar Control of a Simian-Human Immunodeficiency Virus 89.6P Mucosal Challenge by Modified Vaccinia Virus Ankara (MVA) and DNA/MVA Vaccines

Journal of Virology, 2002-08, Vol.76 (15), p.7625-7631

2002

Link zum Volltext

Verfügbarkeit prüfen

Microarray Profiling of Antibody Responses against Simian-Human Immunodeficiency Virus: Postchallenge Convergence of Reactivities Independent of Host Histocompatibility Type and Vaccine Regimen

Journal of Virology, 2003-10, Vol.77 (20), p.11125-11138

2003

Link zum Volltext

Verfügbarkeit prüfen

Poor Immune Responses of Newborn Rhesus Macaques to Measles Virus DNA Vaccines Expressing the Hemagglutinin and Fusion Glycoproteins

Clinical and Vaccine Immunology, 2013-02, Vol.20 (2), p.205-210

2013

Link zum Volltext

Verfügbarkeit prüfen

Co-expression of HIV-1 virus-like particles and granulocyte-macrophage colony stimulating factor by GEO-D03 DNA vaccine

Human vaccines & immunotherapeutics, 2012-11, Vol.8 (11), p.1654-1658

2012

Link zum Volltext

Verfügbarkeit prüfen

CD40L-adjuvanted DNA/modified vaccinia virus Ankara simian immunodeficiency virus SIV239 vaccine enhances SIV-specific humoral and cellular immunity and improves protection against a heterologous SIVE660 mucosal challenge

Journal of virology, 2014-09, Vol.88 (17), p.9579-9589

2014

Link zum Volltext

Verfügbarkeit prüfen

Phase 1 Clinical Trials of the National Institutes of Health Vaccine Research Center HIV/AIDS Candidate Vaccines

The Journal of infectious diseases, 2006-12, Vol.194 (12), p.1625-1627

2006

Link zum Volltext

Verfügbarkeit prüfen

T cell vaccines for microbial infections

Nature medicine, 2005-04, Vol.11 (4 Suppl), p.S25-S32

2005

Link zum Volltext

Verfügbarkeit prüfen

Phase 1 Safety and Immunogenicity Testing of DNA and Recombinant Modified Vaccinia Ankara Vaccines Expressing HIV-1 Virus-like Particles

The Journal of infectious diseases, 2011-03, Vol.203 (5), p.610-619

2011

Link zum Volltext

Verfügbarkeit prüfen

HIV-1 gp120 and Modified Vaccinia Virus Ankara (MVA) gp140 Boost Immunogens Increase Immunogenicity of a DNA/MVA HIV-1 Vaccine

Journal of virology, 2017-12, Vol.91 (24)

2017

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 230

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(190)
Mit Volltextzugriff
(208)

Publikationsform

Sprache

Englisch
(230)
Japanisch
(17)

Erscheinungsjahr

n.n

Thema

Science & Technology
(156)
Life Sciences & Biomedicine
(141)
Animals
(122)
Humans
(81)
Virology
(77)
Immunology
(56)
Vaccines, Dna - Immunology
(56)
Microbiology
(50)
Biological And Medical Sciences
(49)
Fundamental And Applied Biological Sciences. Psychology
(42)
Female
(40)
Macaca Mulatta
(39)
Aids Vaccines - Immunology
(36)
Mice
(35)
Vaccination
(33)
Cd8-Positive T-Lymphocytes - Immunology
(29)
Vaccines
(29)
Viruses
(29)
Hiv-1 - Immunology
(28)
Mice, Inbred Balb C
(28)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Virology
(28)
Virology
(24)
Time
(23)
Vaccine
(14)
Aids Research And Human Retroviruses
(13)
The Journal Of Infectious Diseases
(10)
Proceedings Of The National Academy Of Sciences - Pnas
(8)
Nature Medicine
(7)
The Journal Of Immunology
(7)
Time Canada
(6)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A Zika Vaccine Targeting NS1 Protein Protects Immunocompetent Adult Mice in a Lethal Challenge Model

Multiple-Cytokine-Producing Antiviral CD4 T Cells Are Functionally Superior to Single-Cytokine-Producing Cells

Ebola virus - prospects for a novel virus-like-particle-expressing modified vaccinia Ankara-based vaccine

A Single Dose of Modified Vaccinia Ankara expressing Ebola Virus Like Particles Protects Nonhuman Primates from Lethal Ebola Virus Challenge

HIV/AIDS Vaccines: 2018

Breakthrough of SIV strain smE660 challenge in SIV strain mac239-vaccinated rhesus macaques despite potent autologous neutralizing antibody responses

DNA/MVA Vaccination of HIV-1 Infected Participants with Viral Suppression on Antiretroviral Therapy, followed by Treatment Interruption: Elicitation of Immune Responses without Control of Re-Emergent Virus

HIV transmitted/founder vaccines elicit autologous tier 2 neutralizing antibodies for the CD4 binding site

Immunogenicity of a novel Clade B HIV-1 vaccine combination: Results of phase 1 randomized placebo controlled trial of an HIV-1 GM-CSF-expressing DNA prime with a modified vaccinia Ankara vaccine boost in healthy HIV-1 uninfected adults

DNA and virus particle vaccination protects against acquisition and confers control of viremia upon heterologous simian immunodeficiency virus challenge

Human Immunodeficiency Virus Type 1 Controllers but Not Noncontrollers Maintain CD4 T Cells Coexpressing Three Cytokines

Preclinical Studies of Human Immunodeficiency Virus/AIDS Vaccines: Inverse Correlation between Avidity of Anti-Env Antibodies and Peak Postchallenge Viremia

Non-neutralizing antibodies in prevention of HIV infection

Meta-analysis of HIV-1 vaccine elicited mucosal antibodies in humans

One Group's Historical Reflections on DNA Vaccine Development

Critical Role for Env as well as Gag-Pol in Control of a Simian-Human Immunodeficiency Virus 89.6P Challenge by a DNA Prime/Recombinant Modified Vaccinia Virus Ankara Vaccine

Different Patterns of Immune Responses but Similar Control of a Simian-Human Immunodeficiency Virus 89.6P Mucosal Challenge by Modified Vaccinia Virus Ankara (MVA) and DNA/MVA Vaccines

Microarray Profiling of Antibody Responses against Simian-Human Immunodeficiency Virus: Postchallenge Convergence of Reactivities Independent of Host Histocompatibility Type and Vaccine Regimen

Poor Immune Responses of Newborn Rhesus Macaques to Measles Virus DNA Vaccines Expressing the Hemagglutinin and Fusion Glycoproteins

Co-expression of HIV-1 virus-like particles and granulocyte-macrophage colony stimulating factor by GEO-D03 DNA vaccine

CD40L-adjuvanted DNA/modified vaccinia virus Ankara simian immunodeficiency virus SIV239 vaccine enhances SIV-specific humoral and cellular immunity and improves protection against a heterologous SIVE660 mucosal challenge

Phase 1 Clinical Trials of the National Institutes of Health Vaccine Research Center HIV/AIDS Candidate Vaccines

T cell vaccines for microbial infections

Phase 1 Safety and Immunogenicity Testing of DNA and Recombinant Modified Vaccinia Ankara Vaccines Expressing HIV-1 Virus-like Particles

HIV-1 gp120 and Modified Vaccinia Virus Ankara (MVA) gp140 Boost Immunogens Increase Immunogenicity of a DNA/MVA HIV-1 Vaccine

Suchergebnisse filtern